Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Charcot neuroarthropathy in the era of HAART.

Oh-Park M, Dove C, Sheskier S, Sheehan P.

Lancet. 2006 Jan 21;367(9506):274. No abstract available.

PMID:
16427498
2.

Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.

Moanna A, Rimland D.

Clin Infect Dis. 2013 Jul;57(1):122-5. doi: 10.1093/cid/cit165. Epub 2013 Mar 13.

PMID:
23487391
3.

The neuropathology of HIV infection in the era of Highly Active AntiRetroviral Therapy (HAART).

Gray F, Keohane C.

Brain Pathol. 2003 Jan;13(1):79-83. Review. No abstract available.

PMID:
12580547
4.

Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.

Floris-Moore M, Lo Y, Klein RS, Budner N, Gourevitch MN, Moskaleva G, Schoenbaum EE.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):331-7.

PMID:
14600580
5.

Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.

Hung CC, Hung MN, Hsueh PR, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Huang YT, Lo YC, Hsiao CF, Chang SC.

Clin Infect Dis. 2007 Sep 1;45(5):e60-7. Epub 2007 Jul 19.

PMID:
17682981
6.

Recurrent myelopathy after HAART in a patient with spinal mycobacterial infection.

Sumner CJ, Newman M, Jay CA.

Neurology. 2003 Jul 8;61(1):139-40. No abstract available.

PMID:
12847179
7.

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.

Infection. 2005 Oct;33(5-6):345-9.

PMID:
16258865
8.

HIV-related lung cancer in the era of highly active antiretroviral therapy.

Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, Gazzard B.

AIDS. 2003 Feb 14;17(3):371-5.

PMID:
12556691
9.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

10.

High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.

Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, Hammer J, Carpenter CC, Kojic E, Patel P, Brooks JT; SUN Study Investigators.

Clin Infect Dis. 2011 Feb 1;52(3):378-86. doi: 10.1093/cid/ciq066. Epub 2010 Dec 9.

PMID:
21217185
11.

Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era.

Chiappini E, Berti E, Gianesin K, Petrara MR, Galli L, Giaquinto C, de Martino M, De Rossi A.

Cancer Lett. 2014 May 28;347(1):38-45. doi: 10.1016/j.canlet.2014.02.002. Epub 2014 Feb 7. Review.

12.

[Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].

Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J.

Lijec Vjesn. 2005 May-Jun;127(5-6):123-8. Croatian.

PMID:
16281473
13.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103).

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
14.

Nonmelanoma skin cancers among HIV-infected persons in the HAART era.

Garlassi E, Harding V, Weir J, Francis N, Nelson M, Newsom-Davis T, Bower M.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e63-5. doi: 10.1097/QAI.0b013e318251b004. No abstract available.

PMID:
22622078
15.
16.

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC.

Hepatology. 2004 Jul;40(1):115-9.

PMID:
15239093
17.

How does HIV impact on non-AIDS events in the era of HAART?

Barber TJ, Hughes A, Dinsmore WW, Phillips A.

Int J STD AIDS. 2009 Jan;20(1):1-3. doi: 10.1258/ijsa.2008.008302. Review.

PMID:
19103883
18.

Ocular problems in Brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era.

Rodrigues ML, Rodrigues Mde L, Figueiredo JF, de Freitas JA.

Braz J Infect Dis. 2007 Apr;11(2):199-202.

19.

Impact of depression on HIV outcomes in the HAART era.

Hartzell JD, Janke IE, Weintrob AC.

J Antimicrob Chemother. 2008 Aug;62(2):246-55. doi: 10.1093/jac/dkn193. Epub 2008 May 2. Review.

PMID:
18456650
20.

Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.

Wu PY, Hung CC, Liu WC, Hsieh CY, Sun HY, Lu CL, Wu H, Chien KL.

J Antimicrob Chemother. 2012 Apr;67(4):1001-9. doi: 10.1093/jac/dkr558. Epub 2012 Jan 9.

PMID:
22232517

Supplemental Content

Support Center